Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

The marketing authorisation for Sanofi’s dengue vaccine Dengvaxia has been revoked in the Philippines after the country’s Food and Drug...
Japanese pharma firm Astellas has lifted the curtain on new data for its androgen receptor signalling inhibitor Xtandi (enzalutamide), when...
Smoking may limit the body’s ability to fight melanoma, according to a study published in the journal Cancer Research.
New interim data for the combination of Pfizer’s Bavencio (avelumab) and Merck KGaA’s Inlyta (axitinib) have been released, showing that the pair “...
Scientists at the Medical College of Georgia at Augusta University were able to directly activate a gene associated with depression and thus...
Merck & Co’s Keytruda (pembrolizumab) in combination with Pfizer’s Inlyta (axitinib) significantly extended the lives of those with advanced...
- Janssen's esketamine drug recommended by FDA panel for depression - Researchers find new type of cell membrane which causes cancer cells to explode...
NICE has announced its decision to authorise the use of Roche’s Perjeta (pertuzumab) on the NHS for the treatment of HER2-positive breast cancer...
Takeda’s Adcetris has seen its marketing authorisation expanded by the European Commission to include the treatment of previously untreated CD30+...
The FDA has taken the decision to authorise the use of Novartis’ Egaten in patients older than six years old for the treatment of fascioliasis, a...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches